Information Provided By:
Fly News Breaks for February 5, 2018
PRTA
Feb 5, 2018 | 06:55 EDT
Nomura Instinet analyst Christopher Marai recommends using the weakness in shares of Prothena following the resignation of Chief Medical Officer Sarah Noonberg as a buying opportunity. The analyst keeps a Buy rating on the shares with an $87 price target.
News For PRTA From the Last 2 Days
There are no results for your query PRTA